E10-E14
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Subjects were included if they belonged to the risk group and were thus medically diagnosed with type 1 or type 2 diabetes, had an HbA1c = 7.5% and pronounced diabetes-related psychosocial stress (determined by Problem Areas in Diabetes Questionnaire - Short Form (PAID-SF) with values = 11 (35) or clinical impression), and had sufficient German language skills and cognitive abilities to participate in the study. Inclusion will be exclusively after informed written consent. Physicians who a) work in the diabetes clinic or b) work in the diabetology focus practice and are involved in the treatment of the addressed patient population should be included. Psychologists: Include psychologists who work in the diabetes clinic and are involved in the treatment of the addressed patient population. Medical Assistants: Since it is to be assumed that in the diabetology practices the handing out of a screening form or the connection to psychosomatics, psychiatrists or medical psychotherapists is not exclusively carried out by physicians, medical assistants are also to be included in order to record their needs at the time of referral. Administrative staff: Analogous to the specialized practices, it can also be assumed in the Diabe-tes Clinic that the handing out of a screening form or the connection to psychosomatics, psychiatrists or medical psychotherapists in private practice is not exclusively carried out by physicians. Since different specialist staff work in the clinic, administrative staff should be included here (not bound to a specific occupational group) in order to record their needs during the referral process.
Exclusion criteria
Exclusion criteria: Patients with a diagnosis of type 3 diabetes or gestational diabetes, severe comorbid disease (e.g., current oncologic disease modifying the indication for metabolic control), limitations that, in the judgment of the clinician, significantly limit the ability to participate in the study (e.g., dementia, major depressive episode, psychosis, or addiction), and bedriddenness or need for nursing care will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| I.Needs for specific referral pathways I.a. The needs for referral pathways to PsIA, especially regarding acceptance, feasibility, barriers and facilitators, will be investigated in order to map possible referral pathways and to derive recommendations for their implementation (MRC Framework - Phase I: Development of Referral Pathways). Both patients and providers and their respective specific perspectives will be considered. I.b. The knowledge gained in this context will also be used to develop -specific short questionnaires for patients and service providers, which will make it possible to quantify the acceptance and feasibility as well as any barriers that may still exist in an economical and targeted manner, and thus to determine whether the selected referral pathways are proving effective in routine practice. II. Development of the intervention psy-PADGroup and integration into the PsIA The already tested and manualized psy-PAD intervention is designed as a short-term intervention and is to be adapted and further developed in a manualized form as a psy-PAD group for a group setting in order to be able to be integrated into the structures of the PsIAs as part of an interdisciplinary multimodal treatment offer (MRC Framework - Pha-se I: Development Intervention). | — |
Countries
Germany
Contacts
Klinik für Psychosomatik und Psychotherapie, Universitätsklinikum Gießen und Marburg, Justus-Liebig-Universität Gießen